CN102575294B - 用于急性肾损伤的诊断和/或预后的方法 - Google Patents

用于急性肾损伤的诊断和/或预后的方法 Download PDF

Info

Publication number
CN102575294B
CN102575294B CN201080044847.XA CN201080044847A CN102575294B CN 102575294 B CN102575294 B CN 102575294B CN 201080044847 A CN201080044847 A CN 201080044847A CN 102575294 B CN102575294 B CN 102575294B
Authority
CN
China
Prior art keywords
expression
mir
cells
nutrient
oxygen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201080044847.XA
Other languages
English (en)
Chinese (zh)
Other versions
CN102575294A (zh
Inventor
马里亚·劳拉·加西亚贝尔梅霍
伊莱亚·阿瓜多弗赖莱
费尔南多·利亚诺加西亚
大卫·萨恩斯莫拉莱斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon Y Cajal
Original Assignee
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon Y Cajal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon Y Cajal filed Critical Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon Y Cajal
Publication of CN102575294A publication Critical patent/CN102575294A/zh
Application granted granted Critical
Publication of CN102575294B publication Critical patent/CN102575294B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CN201080044847.XA 2009-09-04 2010-09-03 用于急性肾损伤的诊断和/或预后的方法 Expired - Fee Related CN102575294B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES200901825A ES2363661B2 (es) 2009-09-04 2009-09-04 Método para el diagnóstico y/o pronóstico de daño renal agudo.
ESP200901825 2009-09-04
PCT/ES2010/070579 WO2011027019A2 (es) 2009-09-04 2010-09-03 Metodo para el diagnostico y/o pronostico de daño renal agudo

Publications (2)

Publication Number Publication Date
CN102575294A CN102575294A (zh) 2012-07-11
CN102575294B true CN102575294B (zh) 2015-07-01

Family

ID=43649710

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201080044847.XA Expired - Fee Related CN102575294B (zh) 2009-09-04 2010-09-03 用于急性肾损伤的诊断和/或预后的方法

Country Status (12)

Country Link
US (1) US20120172248A1 (enExample)
EP (2) EP2474622A4 (enExample)
JP (1) JP5801809B2 (enExample)
CN (1) CN102575294B (enExample)
AU (1) AU2010291137A1 (enExample)
CA (1) CA2773054A1 (enExample)
ES (2) ES2363661B2 (enExample)
IN (1) IN2012DN01910A (enExample)
MX (1) MX2012002333A (enExample)
PT (1) PT3029156T (enExample)
RU (1) RU2629591C2 (enExample)
WO (1) WO2011027019A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI646199B (zh) 2017-10-23 2019-01-01 長庚醫療財團法人林口長庚紀念醫院 用於預測一帶有急性心肌梗塞的人類個體發展出急性腎損傷之風險的方法

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2484779A1 (en) * 2011-02-03 2012-08-08 Medizinische Hochschule Hannover Device and method for analysis of kidney failure
ES2432853B1 (es) * 2011-12-15 2015-03-09 Fundación Para La Investigación Biomédica Del Hospital Universitario Ramón Y Cajal Metodo para el diagnostico y/o pronostico de dano renal agudo
RU2587012C1 (ru) * 2014-10-31 2016-06-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ульяновский государственный университет" Способ прогнозирования острого повреждения почек у больных острым коронарным синдромом
RU2583950C1 (ru) * 2015-05-13 2016-05-10 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ прогнозирования развития острого повреждения почки в условиях тепловой ишемии в эксперименте в зависимости от возраста и пола животных
RU2639465C2 (ru) * 2016-02-24 2017-12-21 федеральное государственное бюджетное образовательное учреждение высшего образования "Ульяновский государственный университет" Способ прогнозирования острого повреждения почек у больных острым коронарным синдромом
EP3500270A1 (en) 2016-08-19 2019-06-26 Fundación Para La Investigación Biomédica Del Hospital Universitario Ramón Y Cajal Mir-127 agents for use in the treatment of renal fibrosis
US11466270B2 (en) 2016-10-04 2022-10-11 Vib Vzw Means and methods to treat inflammatory diseases
RU2666911C2 (ru) * 2016-11-24 2018-09-13 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт общей патологии и патофизиологии" (ФГБНУ "НИИОПП") Способ для прогнозирования метастазирования рака яичников на основе группы генов микроРНК
RU2702023C1 (ru) * 2018-08-17 2019-10-04 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ диагностики острого повреждения почек после органосохраняющего хирургического лечения локализованного рака почки
WO2020071518A1 (ja) * 2018-10-04 2020-04-09 学校法人自治医科大学 急性腎障害特異的バイオマーカー、急性腎障害の診断方法、急性腎障害の検査用キット、動物治療方法、及び急性腎障害用医薬
RU2703399C1 (ru) * 2018-11-02 2019-10-16 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт общей патологии и патофизиологии" (ФГБНУ "НИИОПП") Способ для диагностики рака яичников на основе группы генов микроРНК
RU2724017C1 (ru) * 2019-05-17 2020-06-18 федеральное государственное бюджетное образовательное учреждение высшего образования "Ульяновский государственный университет" Способ прогнозирования острого повреждения почек у больных острым коронарным синдромом с использованием шкалы риска
EP3929308A1 (en) 2020-06-23 2021-12-29 Heinrich-Heine-Universität Düsseldorf Diagnostic methods on renal recovery in individuals suffering from acute kidney injury and suitable biomarkers therefor

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050266418A1 (en) * 2004-05-28 2005-12-01 Applera Corporation Methods, compositions, and kits comprising linker probes for quantifying polynucleotides
WO2007013919A2 (en) * 2005-07-21 2007-02-01 The Johns Hopkins University Methods of detecting and treating acute kidney injury
WO2009038742A2 (en) * 2007-09-20 2009-03-26 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Method for estimating risk of acute kidney injury

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2270605C1 (ru) * 2004-06-18 2006-02-27 Государственное учреждение научный центр здоровья детей РАМН (ГУ НЦЗД РАМН) Способ оценки жизнеспособности почечной паренхимы

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050266418A1 (en) * 2004-05-28 2005-12-01 Applera Corporation Methods, compositions, and kits comprising linker probes for quantifying polynucleotides
WO2007013919A2 (en) * 2005-07-21 2007-02-01 The Johns Hopkins University Methods of detecting and treating acute kidney injury
WO2009038742A2 (en) * 2007-09-20 2009-03-26 Caritas St. Elizabeth's Medical Center Of Boston, Inc. Method for estimating risk of acute kidney injury

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
MicroRNA: a new frontier in kidney and blood pressure research;Mingyu Liang，et al.;《American Journal of Physiology-Renal Physiology》;20090401;第297卷(第3期);F553-F558页 *
microRNA-210 MODULATES ENDOTHELIAL CELL RESPONSE TO HYPOXIA AND INHIBITS THE RECEPTOR TYROSINE-KINASE LIGAND EPHRIN-A3;Pasquale Fasanaro,et al;《the journal of biological chemistry》;20080416;第283卷(第23期);1-14页 *
MicroRNAs and Their Role in Progressive Kidney Diseases;Mitsuo Kato，et al.;《Biology of Renal Disease: Laboratory to Clinic》;20081231;第4卷(第7期);1255-1266页 *
Urinary Biomarkers for Acute Kidney Injury: Perspectives on Translation;Steven G. Coca，et al.;《Clinical Journal of the American Society of Nephrology》;20081231;第3卷(第2期);481-490页 *
Urinary exosomal transcription factors, a new class of biomarkers for renal disease;zhou，H.et al.;《kidney international》;20081231;第74卷(第5期);613-621页 *
肾移植排斥反应中microRNA差异表达研究;蓝慧娟;《中国优秀硕士学位论文全文数据库 医药卫生科技辑》;20080930(第 09 期);E067-55 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI646199B (zh) 2017-10-23 2019-01-01 長庚醫療財團法人林口長庚紀念醫院 用於預測一帶有急性心肌梗塞的人類個體發展出急性腎損傷之風險的方法

Also Published As

Publication number Publication date
ES2363661A1 (es) 2011-08-11
ES2363661B2 (es) 2012-05-30
CN102575294A (zh) 2012-07-11
WO2011027019A3 (es) 2011-04-28
EP3029156A2 (en) 2016-06-08
EP2474622A4 (en) 2013-03-06
WO2011027019A2 (es) 2011-03-10
EP3029156A3 (en) 2016-09-14
EP3029156B1 (en) 2018-11-07
JP2013503617A (ja) 2013-02-04
ES2710332T3 (es) 2019-04-24
JP5801809B2 (ja) 2015-10-28
EP2474622A1 (en) 2012-07-11
CA2773054A1 (en) 2011-03-10
US20120172248A1 (en) 2012-07-05
IN2012DN01910A (enExample) 2015-07-24
PT3029156T (pt) 2019-02-11
RU2012106742A (ru) 2013-10-10
MX2012002333A (es) 2012-06-12
AU2010291137A1 (en) 2012-03-15
RU2629591C2 (ru) 2017-08-30

Similar Documents

Publication Publication Date Title
CN102575294B (zh) 用于急性肾损伤的诊断和/或预后的方法
Stylli et al. miRNA expression profiling of cerebrospinal fluid in patients with aneurysmal subarachnoid hemorrhage
Miguel et al. The program of renal fibrogenesis is controlled by microRNAs regulating oxidative metabolism
US8574838B2 (en) Methods and kits for miRNA isolation and quantitation
CN107385035B (zh) 与2型糖尿病视网膜病变相关的血清/血浆miRNA标志物及其应用
CN104306993B (zh) 循环miR‑505在高血压早期诊断及靶器官早期损伤预警作用中的应用
CN108179194B (zh) 一种肿瘤分子标志物circBIRC6及其抑制剂和用途
WO2013056002A1 (en) Use of microrna for assessing embryos grown in vitro and improving culture media
WO2016186987A1 (en) Biomarker micrornas and method for determining tumor burden
US20170175191A1 (en) Method for the diagnosis and/or prognosis of acute renal damage
WO2020088704A1 (en) Postpartum epigenetic profile of cardiovascular micrornas in women exposed to pregnancy-related complications
CN104962654B (zh) lncRNA-MALAT1在制备增生性玻璃体视网膜病变诊断试剂中的应用
WO2015126886A1 (en) Mir-320e and colorectal cancer
CN111154863B (zh) lncRNA在制备诊断和/或治疗骨关节炎的产品中的应用
ES2374890B1 (es) Método para el diagnóstico y/o pronóstico de daño renal agudo.
CN115198014A (zh) 一种用于胰腺癌早期诊断的外泌体miRNA标志物组合及检测试剂盒
ES2381401A1 (es) Método para el diagnóstico y/o pronóstico de daño renal agudo.
CN114767865A (zh) 血浆外泌体对aaad伴肺损伤药物研制中应用
CN116179687A (zh) 一种糖尿病肾病早期诊断的piRNA生物标志物及其应用
CN114875128A (zh) 与皮肤修复相关的miRNA标志物及其应用
PL241808B1 (pl) Zastosowanie markerów mikroRNA do wykrywania obecności tętniaków aorty brzusznej oraz sposób diagnozowania tętniaków aorty brzusznej

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150701

Termination date: 20190903